Discuss This Drug

romiplostim

CHEBI:CHEBI_748823

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

generic_name
romiplostim
rxcui
2201540
brand_name
Nplate
brand_name_base
Nplate
product_type
DRUG FOR FURTHER PROCESSING
listing_expiration_date
20251231
route
SUBCUTANEOUS
dosage_form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
marketing_start_date
20080825
marketing_category
DRUG FOR FURTHER PROCESSING
active_ingredient_strength
125 ug/.25mL
labeler_name
Amgen Inc
pharm_class_pe
Increased Platelet Production [PE]
pharm_class
Thrombopoietin Receptor Agonists [MoA]
pharm_class_epc
Thrombopoietin Receptor Agonist [EPC]
pharm_class_moa
Thrombopoietin Receptor Agonists [MoA]
manufacturer_name
Amgen Inc
product_ndc
55513-221
application_number
BLA125268
package_marketing_start_date
02-AUG-19
spl_id
eaf1746b-43c7-43d2-940b-dcf912465ef5
active_ingredient_name
ROMIPLOSTIM
package_ndc
55513-221-01
package_description
1 VIAL in 1 CARTON (55513-221-01) / .5 mL in 1 VIAL
unii
GN5XU2DXKV
spl_set_id
c45f9a58-37c1-4f76-8e36-97d38c577037
nui
N0000175968
upc
0355513222013
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class